[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Lu et al., 1996 - Google Patents

Inhibition of prolactin receptor gene expression by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in MCF-7 human breast cancer cells

Lu et al., 1996

Document ID
9303109410276622547
Author
Lu Y
Sun G
Wang X
Safe S
Publication year
Publication venue
Archives of biochemistry and biophysics

External Links

Snippet

Treatment of MCF-7 human breast cancer cells with 10 nM2, 3, 7, 8-tetrachlorodibenzo-p- dioxin (TCDD) did not decrease prolactin receptor (PRLR) binding. In contrast, PRLR mRNA levels were significantly decreased within 12 h after treatment with TCDD and persisted for …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds

Similar Documents

Publication Publication Date Title
Santen et al. Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivity
Corcoran et al. Tissue Inhibitor of Metalloproteinase-2 Stimulates Fibroblast Proliferation via a cAMP-dependent Mechanism∗
Namer et al. Increase of progesterone receptor by tamoxifen as a hormonal challenge test in breast cancer
Planas-Silva et al. Role of c-Src and focal adhesion kinase in progression and metastasis of estrogen receptor-positive breast cancer
Astroff et al. Inhibition of the 17β-estradiol-induced and constitutive expression of the cellular protooncogene c-fos by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) in the female rat uterus
Santen et al. Adaptive hypersensitivity to estrogen: mechanisms and clinical relevance to aromatase inhibitor therapy in breast cancer treatment
Lu et al. Inhibition of prolactin receptor gene expression by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in MCF-7 human breast cancer cells
US5723291A (en) Methods for screening compounds for estrogenic activity
Park et al. RUNX2 transcription factor regulates gene expression in luteinizing granulosa cells of rat ovaries
Cormier et al. Decrease in estradiol-stimulated progesterone receptor production in MCF-7 cells by epidermal growth factor and possible clinical implication for paracrine-regulated breast cancer growth
Pascale et al. Inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase activity and gene expression by dehydrocpiandrosterone in preneoplastic liver nodules
Sarkar et al. Role of transforming growth factor (TGF)-β type I and TGF-β type II receptors in the TGF-β1-regulated gene expression in pituitary prolactin-secreting lactotropes
Tripathi et al. Platelet activating factor induces expression of early response genes c-fos and TIS-1 in human epidermoid carcinoma A-431 cells
AU682398B2 (en) Methods for screening antiestrogen compounds
Varma et al. Antiestrogen ICI 182,780 decreases proliferation of insulin-like growth factor I (IGF-I)-treated MCF-7 cells without inhibiting IGF-I signaling
US20060057628A1 (en) Method for prognosticating the progress of breast cancer and compounds useful for prevention or treatment thereof
Han et al. Ethacrynic acid inhibits multiple steps in the NF-κB signaling pathway
BALASUBRAMANIAN et al. Thapsigargin suppresses phorbol ester-dependent human involucrin promoter activity by suppressing CCAAT-enhancer-binding protein α (C/EBPα) DNA binding
Lee et al. Stimulation of DNA synthesis and c-fos mRNA expression in primary rat hepatocytes by estrogens
Dipippo et al. Tamoxifen and ICI 182,780 interactions with thyroid hormone in the ovariectomized-thyroidectomized rat
Rabin et al. Activation of protein kinase A is necessary but not sufficient for ethanol-induced desensitization of cyclic AMP production.
Hong et al. Differential effects of estradiol and its analogs on cyclin D1 and CDK4 expression in estrogen receptor positive MCF-7 and estrogen receptor-transfected MCF-10AEwt5 cells.
Ricci et al. ECC-1 human endometrial cells as a model system to study dioxin disruption of steroid hormone function
YAMASHITA et al. Plasminogen activator as a functional marker for estrogen dependence in human breast cancer cells
Glantschnig et al. The cellular protooncogenes c-fos and egr-1 are regulated by prostacyclin in rodent osteoblasts and fibroblasts